Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

The 4 analysts that cover Bio-Rad Laboratories stock have a consensus rating of "Buy" and an average price target of $339.75, which forecasts a 12.31% increase in the stock price over the next year. The lowest target is $300 and the highest is $409.

Price Target: $339.75 (+12.31%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$300	$339.75	$340	$409
Change	-0.83%	+12.31%	+12.39%	+35.20%

Analyst Ratings

The average analyst rating for Bio-Rad Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	2	1
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Donnelly Citigroup	Citigroup	Strong Buy → Hold Downgrades $375 → $300	Strong Buy → Hold	Downgrades	$375 → $300	-0.83%	Apr 7, 2026
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $350 → $375	Strong Buy	Maintains	$350 → $375	+23.96%	Oct 30, 2025
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $265 → $340	Hold	Maintains	$265 → $340	+12.39%	Oct 30, 2025
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $387 → $409	Buy	Maintains	$387 → $409	+35.20%	Aug 1, 2025
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $245 → $265	Hold	Maintains	$245 → $265	-12.40%	Aug 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.65B

Increased by 2.59%

from 2.58B

Revenue Next Year

2.74B

Increased by 3.21%

from 2.65B

EPS This Year

10.32

Decreased by -62.95%

from 27.85

EPS Next Year

11.45

Increased by 10.95%

from 10.32

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.92B	2.80B	2.67B	2.57B	2.58B	2.65B	2.74B
Revenue Growth	14.81%	-4.12%	-4.68%	-3.92%	0.65%	2.59%	3.21%
EPS	140.83	-121.79	-21.82	-65.36	27.85	10.32	11.45
EPS Growth	11.35%	-	-	-	-	-62.95%	10.95%
Forward PE	-	-	-	-	-	29.32	26.42
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	2.8B	2.9B
Avg	2.7B	2.7B
Low	2.6B	2.6B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	7.3%	9.0%
Avg	2.6%	3.2%
Low	-1.0%	-1.2%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	11.08	12.55
Avg	10.32	11.45
Low	9.74	10.41

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-60.2%	21.6%
Avg	-62.9%	11.0%
Low	-65.0%	0.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.